Poor ovarian responders: To meta-analyse or not, that is the question

Human Reproduction

Volumn 29, Issue 3, 2014, Pages 634-638

  Polyzos, N P ^a   Tournaye, H ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL DERIVATIVE; LUTEAL ESTRADIOL; UNCLASSIFIED DRUG;

COHORT ANALYSIS; HUMAN; LETTER; META ANALYSIS; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; OOCYTE RETRIEVAL; OVARY CYCLE; OVARY FUNCTION; PREGNANCY RATE; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTION; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; TREATMENT RESPONSE;

ESTRADIOL; FEMALE; HUMANS; LUTEAL PHASE; PREGNANCY;

EID: 84894229184     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det426     Document Type: Letter

References (15)

1. Ata B, Zeng X, Son WY, Holzer H, Tan SL. Follicular synchronization using transdermal estradiol patch and GnRH antagonists in the luteal phase; does it increase oocyte yield in poor responders to gonadotropin stimulation for in vitro fertilization (IVF)? A comparative study with microdose flare-up protocol. Gynecol Endocrinol 2011;27:876-879.
2. Chang EM, Han JE,Won HJ, Kim YS, Yoon TK, Lee WS. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization. J Assist Reprod Genet 2012;29:225-230.
3. DiLuigi AJ, Engmann L, SchmidtDW, BenadivaCA, Nulsen JC.Arandomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders. Fertil Steril 2011;95:2531-2533.
4. Dragisic KG, Davis OK, Fasouliotis SJ, Rosenwaks Z. Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertil Steril 2005;84:1023-1026.
5. Elassar A, Engmann L, Nulsen J, Benadiva C. Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation. Fertil Steril 2011;95:2330-2334.
6. Hill MJ, McWilliams GD, Miller KA, Scott RTJr, Frattarelli JL.Aluteal estradiol protocol for anticipated poor-responder patients may improve delivery rates. Fertil Steril 2009;91:739-743.
7. Humaidan P, Polyzos NP. (Meta)analyze this: systematic reviews might lose credibility. Nat Med 2012;18:1321.
8. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
9. Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 2007;176:1091-1096.
10. Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril 2011;96:1058-61 e7.
11. Polyzos NP, Polyzos IP, Zavos A, Valachis A, Mauri D, Papanikolaou EG, Tzioras S,Weber D, Messinis IE. Obstetric outcomes after treatment of periodontal disease during pregnancy: systematic review and meta-analysis. BMJ 2010;341:c7017.
12. Polyzos NP, Valachis A, Patavoukas E, Papanikolaou EG, Messinis IE, Tarlatzis BC, Devroey P. Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publication. Hum Reprod 2011;26:1371-1376.
13. Reynolds KA, Omurtag KR, Jimenez PT, Rhee JS, Tuuli MG, Jungheim ES. Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis. Hum Reprod 2013;28:2981-2989.
14. Shastri SM, Barbieri E, Kligman I, Schoyer KD, Davis OK, Rosenwaks Z. Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide. Fertil Steril 2011;95:592-595.
15. Weitzman VN, Engmann L, DiLuigi A, Maier D, Nulsen J, Benadiva C. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes. Fertil Steril 2009;92:226-230.